Regulus Therap (RGLS) Reports Q3 Loss of $15.98

Regulus Therap (NASDAQ: RGLS) reported Q3 EPS of ($15.98), versus ($11.68) reported last year. Revenue for the quarter came in at $2.8 million, versus $3.81 million reported last year.

For earnings history and earnings-related data on Regulus Therap (RGLS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day
• Bernstein SocGen on Oracle (ORCL): 'Next catalyst is FAM'